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VPS34 gene function is required for the efficient localization of a variety of vacuolar proteins. We have cloned
and sequenced the wild-type VPS34 gene in order to gain a better understanding of the role of its protein
product in this intracellular sorting pathway. Interestingly, disruption of the VPS34 locus resulted in a
temperature-sensitive growth defect, indicating that the VPS34 gene is essential for vegetative growth only at
elevated growth temperatures. As with the original vps34 alleles, vps34 null mutants exhibited severe vacuolar
protein sorting defects and possessed a morphologically normal vacuolar structure. The VPS34 gene DNA
sequence identifies an open reading frame that could encode a hydrophiic protein of 875 amino acids. The
predicted protein sequence lacks any apparent signal sequence or membrane-spanning domains, su,,gesting
that Vps34p does not enter the secretory pathway. Results from immunoprecipitation experiments with
antiserum prepared against a TrpE-Vps34 fusion protein were consistent with this prediction: a rare,
unglycosylated protein of -95,000 Da was detected in extracts of wild-type Saccharomyces cerevisiae cells. Cell
fractionation studies indicated that a significant portion of the Vps34p is found associated with a particulate
fraction of yeast cells. This particulate Vps34p was readily solubilized by treatment with 2 M urea but not with
Triton X-100, suggesting that the presence of Vps34p in this pelletable structure is mediated by protein-protein
interactions. vps34 mutant cells also exhibited a defect in the normal partitioning of the vacuolar compartment
between mother and daughter cells during cell division. In more than 80% of the Avps34 dividing cells
examined, no vacuolar structures were observed in the newly emerging bud, whereas in wild-type dividing
cells, more than 95% of the buds had a detectable vacuolar compartment. Our results suggest that the Vps34p
may act as a component of a relatively large intracellular structure that functions to facilitate specific steps of
the vacuolar protein delivery and inheritance pathways.
In eucaryotic cells, the secretory pathway is responsible
for the modification and delivery of proteins to a wide
variety of intracellular and extracellular compartments. En-
try into this pathway is mediated by the presence of an
amino-terminal signal sequence and results in translocation
across the endoplasmic reticulum (ER) membrane. Proteins
destined for secretion are subsequently delivered from the
ER to the Golgi complex and then from the Golgi complex to
the cell surface via specific membrane-enclosed transport
vesicles. This interorganellar flow of proteins from the ER to
the cell surface appears to occur by a default mechanism;
proteins that lack an intracellular "address" are passively
carried to the cell surface (32). However, proteins resident
within the ER, Golgi, or lysosomal compartment are char-
acterized by the presence of specific retention or sorting
signals which are responsible for their accurate subcellular
localizations (22, 32). Therefore, mechanisms must exist to
allow the cell to recognize and distinguish these various
sorting signals and to ultimately deliver the marked proteins
to their appropriate intracellular compartments.
Genetic and biochemical studies of protein secretion in the
yeast Saccharomyces cerevisiae have demonstrated that
many of the essential features of the secretory pathway have
been conserved in all eucaryotes, from yeasts to mammals
(28, 29). In particular, the delivery of proteins to the yeast
cell surface also appears to proceed through the ER and
Golgi compartments by a bulk flow, or default, mechanism.
As with mammalian lysosomal enzymes, proteins destined
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for the yeast lysosome-like vacuole depend on the presence
of additional sorting information (15, 19, 20, 52). Genetic
studies indicate that vacuolar proteins transit through the
early stages of the secretory pathway together with proteins
destined for secretion or assembly into the plasma mem-
brane (15, 48, 52). Within the Golgi compartment, the
vacuolar proteins are segregated away from proteins des-
tined for secretion and targeted to the yeast vacuole.
In an attempt to identify cellular components involved in
the specific segregation, packaging, and delivery of proteins
to the vacuole, we used a gene fusion-based selection
scheme to isolate a large number of yeast mutants defective
in vacuolar protein localization or processing (2, 36). More
than 600 vpt (for vacuolar protein targeting defective) mu-
tants have been isolated, and the recessive mutations have
been assigned to at least 33 complementation groups. The
vpt mutations have been demonstrated to affect the intra-
cellular sorting of a variety of vacuolar proteins, including
the soluble hydrolases carboxypeptidase Y (CPY), protein-
ase A (PrA), and proteinase B (PrB), and an integral mem-
brane protein, repressible alkaline phosphatase (2, 20, 36). In
addition to the observed sorting defects, analysis by both
light and electron microscopy techniques has demonstrated
that several of the vpt mutants possess morphologically
abnormal vacuolar structures (3). These observations have
allowed us to assign the vpt mutants to three distinct classes
based on their vacuole morphology. The majority of mu-
tants, class A, possess one to three large vacuoles per cell,
similar to what is seen in wild-type cells. In other vpt
complementation groups, the cells are characterized either
by the presence of multiple, small vacuolelike organelles
(class B mutants) or by the apparent lack of any normal
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TABLE 1. Strains used
* ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ReferenceStrain Genotype or source
S. cerevisiae
SEY6210 MATa leu2-3,112 ura3-52 his3-A200 trpl-A&901 lys2-801 suc2-A9 36
SEY6211 MATa leu2-3,112 ura3-52 his3-A200 trpl-A901 ade2-101 suc2-A9 36
SEY34-2 SEY6210 vps34-2 36
SEY34-6 SEY6211 vps34-6 36
PHY102 SEY6210 vps34AJ1::TRPI This study
PHY103 SEY6211 vps34AJ::TRPI This study
DKY6224 MATa, leu2-3,112 ura3-52 his3-A200 trpl-A&901 ade2-101 suc2-A9 Apep4: :LEU2 19
SEY6210.5 MATTalMATa leu2-3,1121leu2-3,112 ura3-521ura3-52 his3-A200/his3-A200 trpi- This study
A901/trpl-A901 suc2-A9lsuc2-A9 ADE2Iade2-101 lys2-8011L YS2
PHY120 Same as SEY6210.5 except VPS341vps34Al::TRPI This study
E. coli
MC1061 F- hsdR hsdM+ araD139 (araABOIC-leu)7679 (lac)X74 galU galK rpsL 5a
JM101 F' traD36 lacIq AM15 proAB Alac(lac-pro) supE thi 27
vacuolar structures (class C mutants). In addition to the vpt
mutants, two other sets of mutants (pep and vpl) that affect
vacuolar protein localization or processing have been de-
scribed (16, 21, 38, 40). The vpl mutants were also identified
by selecting for mutants defective in vacuolar protein local-
ization (38, 40). Genetic analysis has demonstrated that
significant overlap exists between the VPT and VPL com-
plementation groups, and the vpt and vpl mutants are now
collectively referred to as vps, for vacuolar protein sorting
defective (36, 38). The pep mutants were originally identified
in genetic screens for yeast mutants exhibiting decreased
levels of CPY activity (16), and subsequent-analysis has
shown that most of the pep mutants also exhibit vacuolar
protein sorting defects (38). In all, the mutants in these
different collections define more than 47 complementation
groups which appear to be required for the delivery of
soluble vacuolar hydrolases such as CPY (21). These initial
genetic studies, therefore, indicate that vacuolar protein
delivery is a complex process that involves the direct or
indirect participation of a relatively large number of gene
functions. To functionally dissect this pathway and gain an
understanding of the underlying molecular mechanisms, we
have initiated efforts to clone specific VPS genes and to
characterize their respective gene products.
Eight independent mutant alleles of the VPS34 locus were
originally isolated in a genetic selection for yeast vacuolar
protein targeting mutants (36). vps34 mutant cells were
observed to exhibit severe defects in the sorting of the
soluble vacuolar hydrolases, CPY, PrA, and PrB. However,
light microscopy analyses revealed that vps34 cells contain
morphologically normal vacuoles (class A; 3). This latter
observation indicated that vps34 cells are competent for
vacuole assembly; in combination, these observations sug-
gested that the wild-type VPS34 gene product might be
specifically involved in the intracellular sorting and delivery
of soluble vacuolar proteins. However, an electron micros-
copy analysis of vps34 mutants has demonstrated that in
addition to a morphologically normal vacuole, vps34 cells
accumulate a variety of abnormal membranous structures
within their cytoplasm, including Berkeley bodies and 80-nm
vesicles (3). Similar membrane-enclosed material was also
observed in class C vps mutants, which lack a detectable
normal vacuolar compartment. vps34 cells have several
other phenotypes in common with the class C vps mutants,
including sensitivity to osmotic stress and extreme temper-
ature-sensitive growth defects (3, 36). This phenotypic sim-
ilarity to yeast mutants that are defective in the assembly of
the vacuolar compartment might also suggest a role for the
VPS34 gene product in vacuole biogenesis.
Toward a better understanding of the role of the VPS34
gene product in vacuolar protein sorting and biogenesis, we
report here on the cloning and sequencing of the VPS34
gene, the phenotypic consequences of a VPS34 null allele
(Avps34), and the identification and localization of the
VPS34 gene product. Our results suggest that Vps34p is a
relatively rare yeast polypeptide that may function as a
component of a large intracellular multiprotein structure to
facilitate vacuolar protein delivery.
MATERIALS AND METHODS
Strains and media. The S. cerevisiae and Escherichia coli
strains used are listed in Table 1. The yeast strains were
constructed by standard genetic techniques (46). Standard
yeast (46) and E. coli (27) media were used and supple-
mented as needed.
Reagents. DNA restriction and modifying enzymes were
from either New England BioLabs, Inc. (Beverley, Mass.),
or Boehringer Mannheim Biochemicals (Indianapolis, Ind.).
Zymolyase-100T (Kirin Brewery Co.) was obtained from
Seikagako Kogyo Co. (Tokyo, Japan), lyticase was from
Enzogenetics, and 5-bromo-4-chloro-3-indoyl-p-D-galacto-
side (X-Gal), phenylmethanesulfonyl fluoride, and isopro-
pyl-p-D-thiogalactopyranoside (IPTG) were from Boehringer
Mannheim Biochemicals. Tran 35S label was from ICN
Radiochemicals (Irvine, Calif.), [ot-32PICTP and [a-35S]
dATP were from Amersham (Arlington Heights, Ill.), Auto-
fluor was from Dupont, NEN Research Products (Boston,
Mass.), 5(6)-carboxy-2'-7'-dichlorofluorescein diacetate
(CDCFDA) was from Molecular Probes, Inc. (Eugene,
Ore.), and RNasin was from Promega Biotec (Madison,
Wis.). Sequenase enzyme and the Sequenase DNA sequenc-
ing kit were from United States Biochemicals (Cleveland,
Ohio), the T3/IT7 RNA transcription kit was from Stratagene
(La Jolla, Calif.), and the polymerase chain reaction (PCR)
Gene Amp DNA amplification kit was from Perkin Elmer
Cetus (Norwalk, Conn.). All other chemicals were pur-
chased from Sigma Chemical Co. (St. Louis, Mo.). Antise-
rum to phosphoglycerokinase was a gift from Jeremy
Thorner, and the antiserum to CPY was described previ-
ously (19).
Recombinant DNA methods and plasmid constructions. All
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recombinant DNA manipulations were done as previously
described (25).
The yeast E. coli shuttle vector, pPHYC18, was con-
structed from pSEYC68 in two steps. pSEYC68 is a deriv-
ative of plasmid pSEYC58 (11) in which the pUC8 polylinker
sequences have been replaced with those of pUC18. First,
pSEYC68 DNA was digested with XhoI and HpaI, and the
XhoI 3'-recessed ends were filled in with Klenow polymer-
ase. These two blunt ends were subsequently ligated to
remove -600 bp from the CEN4 region of pSEYC68. This
deletion removed the only KpnI site in pSEYC68 and did not
affect the mitotic stability of the resultant yeast plasmid,
pPHYC16 (data not shown; see reference 26). The polylinker
sequences of pPHYC16 were then replaced with the poly-
linker from pBluescript KS(+) (pBP; Stratagene) by replac-
ing the -400-bp PvuII fragment of pPHYC16 with that from
the pBP plasmid to yield pPHYC18. The -5.0-kb ClaI-SacI
fragment of pPHY34 was subcloned into pBP (KS+) to yield
plasmid pPHY46. This VPS34-containing fragment was then
removed as a SalI-SacI fragment and subcloned into
pSEY18 (a derivative of pSEY8 with pUC18 polylinker
sequences; 11) to make pPHY52, a multicopy VPS34 plas-
mid.
The yeast integrating vector, pPHYI10, was constructed
by inserting the -800-bp EcoRI-PstI fragment of YRp7,
which contains the yeast TRPI gene (51), into the NdeI site
of pUC18. All restriction enzyme ends were filled in or
digested with Klenow polymerase to create blunt ends. This
plasmid contains a yeast selectable marker, TRPI, but no
yeast origin of replication.
Plasmid pPHY40 was used to construct exonuclease III-
mung bean nuclease deletions of VPS34 sequences in an
attempt to define the minimum complementing fragment and
was constructed as follows. The original YCp5O comple-
menting plasmid, pPHY34, was digested with KpnI, and the
3' overhang ends were removed by treatment with mung
bean nuclease. The plasmid was then digested with ClaI, and
this 4.1-kb ClaI-KpnI (blunt) fragment was subcloned into
ClaI-Smal-digested pPHYC18 to yield pPHY40. Plasmids
pPHY42 and pPHY43 were constructed by subcloning the
VPS34 locus, as a -4.1-kb KpnI-SacI fragment from
pPHY40, into pBP (-) and pBP (+), respectively (both pBP
plasmids were of the KS series).
The integrative mapping plasmid, pPHY35, was con-
structed by cloning the 3.4-kb BamHI-SacI fragment of
pPHY34 into the pPHYI10 vector. Plasmid pPHY38 was
used to make a gene disruption of the VPS34 locus and was
constructed in multiple steps, as follows. First, the 4.1-kb
ClaI-KpnI fragment of pPHY34 was subcloned into the
pPHYC18 yeast vector. This VPS34-containing DNA frag-
ment was subsequently removed as a PstI-KpnI fragment
and subcloned into pUC18, to construct pPHY36. pPHY36
was digested with XhoI, the XhoI 3'-recessed ends were
filled in, and the plasmid was then cut with BamHI. The
yeast TRPI gene was subcloned into this plasmid as an
EcoRI (blunt)-BglII fragment from YRp7, where the EcoRI
3'-recessed ends were filled in with Klenow polymerase.
Plasmid pPHY34.17 was made by cloning the 1.0-kb BamHI-
XhoI fragment of pPHY34 into pPHYC18.
Northern (RNA) analysis. Yeast RNA was prepared as
previously described (10). Poly(A)+ RNA was isolated by
binding total yeast to oligo(dT)-cellulose in the presence of
0.5 M LiCl, extensive washing with the high-salt buffer, and
then batch elution with 10 mM Tris hydrochloride (pH 7.5)-l
mM EDTA. The RNA was subsequently electrophoresed on
formaldehyde-1% agarose gels and transferred to Gene-
Screen membranes (1). Single-stranded [32P]RNA probes
were prepared by transcription from pPHY34.17 with either
T3 or T7 RNA polymerase and were hybridized to the RNA
blot as described previously (1).
Yeast genetics. Standard yeast genetics techniques were
used throughout (46). Yeast transformation was achieved by
the method of alkali cation treatment (14), and transformants
were selected on SD medium.
The VPS34 gene was cloned by complementing the severe
temperature-sensitive growth defect associated with the
vps34-2 allele. SEY34-2 cells (vps34-2 ura3-52) were trans-
formed with a yeast genomic DNA library constructed in
plasmid YCp5O (37), and Ura+ transformants were selected
at 26°C. Transformant colonies were subsequently replicated
to 37°C YPD plates, and plasmids conferring a temperature-
resistant phenotype upon the cells were isolated and ana-
lyzed. Plasmid DNA was isolated from yeast cells by resus-
pension of a moderately large colony in 0.2 ml of 10 mM Tris
hydrochloride (pH 7.5)-i mM EDTA and extraction two
times with a 50:50 phenol-chloroform mixture. The DNA
was precipitated from the aqueous phase and used to trans-
form competent E. coli cells to ampicillin resistance.
To construct a gene disruption of the VPS34 locus, the
2.7-kb HindIII-KpnI fragment of pPHY38 was gel isolated
(from a partial digestion) and used to transform the diploid
yeast strain, SEY6210.5, and the haploid strains, SEY6210
and SEY6211, to tryptophan prototrophy. For integrative
mapping, plasmid pPHY35 was digested with XhoI and
transformed into SEY6211. Trp+ transformants were se-
lected and subsequently crossed to the yeast strain SEY34-2
for genetic analysis.
PCR analysis of yeast genomic DNA. Approximately 0.2
OD6. (optical density at 600 nm) equivalents of a yeast
culture were pelleted and resuspended in 200 ,ul of H20.
Glass beads (0.55 mm) were added, and the cells were
broken by vigorous vortexing for 60 s. The lysates were
centrifuged for 2 min at 13,000 x g to remove cell debris, and
10 ,ul of this cleared lysate was used as the genomic DNA
template. The PCR reactions were performed as described in
the Perkin Elmer Cetus Gene Amp DNA amplification kit.
The nucleotide sequences of the primers are as follows: 1,
ATAACATCTCCGTGAAGCATTGAGG; 2, TACGTGAT
TAAGCACACAAAGGCAG; and 3, TTTAATGTCCGGC
TTCACTTGCTTG (5' to 3'). Before addition of the TaqI
polymerase, the reaction mixes were heated to 94°C for 10
min. TaqI enzyme was added, and 30 cycles of amplification
were carried out, with the typical cycle consisting of 2 min at
55°C (annealing), 3 min at 72°C (extension), and 1 min at
94°C (denaturation). The reaction products were analyzed on
1.2% agarose gels stained with ethidium bromide. Since
these PCR primers are contained within the transforming
DNA fragment, we analyzed the genomic DNA from haploid
progeny of independent PHY120 meioses to ensure that
integration had occurred at the VPS34 locus. We have also
disrupted the VPS34 gene with the 2.1-kb AlwNI fragment of
pPHY38 (primer 1 is upstream of the 5'-most AlwNI site) and
have obtained identical results in the subsequent PCR anal-
ysis.
Preparation of antisera against Vps34p. A gene fusion
between E. coli trpE gene and VPS34 was constructed by
using the pATH vector system (8). We subcloned the 1.0-kb
XbaI-XhoI fragment of pPHY34 into XbaT-SalI-digested
pATH2 DNA to produce plasmid pPHY51.1, which encodes
a TrpE-Vps34p fusion protein containing 338 amino acids of
Vps34p. This TrpE fusion protein was induced and prepared
as previously described (18) except that 2% Triton X-100
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VACUOLAR PROTEIN SORTING IN S. CEREVISIAE 6745
was used instead of 0.2% Nonidet P-40. Protein induction
was examined by analyzing whole-cell lysates on sodium
dodecyl sulfate (SDS)-polyacrylamide gels stained with
Coomassie blue. A large-scale preparation of the fusion
protein was electrophoresed and eluted from a 9% prepara-
tive SDS-polyacrylamide gel. The protein eluant was mixed
with Freund adjuvant and injected into New Zealand White
male rabbits (-150 ,g per rabbit). Antiserum was collected
after multiple secondary injections.
DNA sequencing and sequence analysis. Exonuclease III-
mung bean nuclease deletions were performed on plasmids
pPHY42 and pPHY43 as described in the Stratagene Blue-
script manual except that following nuclease digestion the
treated DNA was eluted from a 1% agarose gel. Single-
stranded phagemid DNA was purified following M13 super-
infection, and the single-stranded DNA templates were
sequenced by using standard dideoxy-chain termination
techniques (44).
The predicted protein sequence of Vps34p was compared
with the contents of the National Biomedical Research
Foundation (NBRF) protein data base (release 21.0, June
1989) with the FASTA program and the contents of the
GenBank data base (release 60.0, June 1989) with the
TFASTA program (31). The comparisons were performed
with the University of Wisconsin Genetics Computer Group
sequence analysis package for VAX/VMS computers (6).
Cell labeling and immunoprecipitation. Immunoprecipita-
tions from whole cells were performed as previously de-
scribed (19), with the following modifications. Yeast cells
were grown to mid-logarithmic phase in yeast nitrogen base
(YNB) minimal medium supplemented with the appropriate
amino acids. Two units of cells at an OD6. of 1.0 was
centrifuged and resuspended in 0.5 ml of the same medium.
Bovine serum albumin (final concentration, 1 mg/ml) and 150
,uCi of Tran 35S label were added to this culture, and the cells
were incubated for 20 to 30 min at the appropriate temper-
ature. A chase, if necessary, was initiated by adding cold
methionine to a final concentration of 2 mM. The labeling or
chase reaction was terminated by the addition of trichloro-
acetic acid (TCA) to a final concentration of 5%. The
remaining steps were as described (19) except that only two
immunoprecipitation washes were performed, one with IP
buffer (0.5% Tween 20, 50 mM Tris hydrochloride [pH 7.5],
150 mM NaCl, 0.1 mM EDTA) and one with IP buffer 2 (50
mM Tris hydrochloride [pH 7.5], 150 mM NaCl, 0.1 mM
EDTA). The samples were electrophoresed on 8% SDS-
polyacrylamide gels. To assess N-linked oligosaccharide
modification, the cells were incubated in the presence of
tunicamycin (20 ,ug/ml) for 15 min prior to labeling. The CPY
fractionation immunoprecipitations were done as previously
described (36).
Fractionation of Vps34p. Strain DKY6224 (Apep4) harbor-
ing plasmid pPHY52 was grown at 30°C to an ODwo of -0.7
in YNB-glucose minimal medium. Cells were pelleted and
incubated with 100 mM Tris-sulfate (pH 9.4)-10 mM dithio-
threitol for 15 min at 30°C. The cells were pelleted and
resuspended in YNB-glucose medium (pH 7.5) supple-
mented with 1.3 M sorbitol. Oxylyticase was added to 40 U
per OD6. equivalent, and the cells were spheroplasted for
20 min at 30°C. The spheroplasts were pelleted and labeled in
YNB-glucose-1.3 M sorbitol medium with Trans 35S label
(300 ,uCi/ml) for 30 min at 30°C. NaF and NaN3 were added
to 10 mM, and the cultures were immediately put on ice. The
labeled spheroplasts were gently pelleted at 2,000 x g and
then resuspended in 1.2 M sorbitol-100 mM Tris hydrochlo-
ride (pH 7.5)-10 mM EDTA containing phenylmethylsulfo-
nyl fluoride (1 mg/ml), leupeptin (50 ,ug/ml), and pepstatin A
(14 ,ug/ml). The cells were osmotically lysed by the rapid
addition of 10 volumes of lysis buffer (0.25 M sucrose, 100
mM Tris hydrochloride [pH 7.5], 10 mM EDTA, 1 mg of
bovine serum albumin per ml; 10). The unlysed cells were
removed by centrifugation at 500 x g for 2 min. The resulting
supernatant was separated into four equal aliquots, and 0.2
volume of one of the following was added: distilled water,
5% Triton X-100, 10 M urea, or 5 M NaCl. The lysate
solutions were incubated at 0°C for 10 min and then centri-
fuged at 100,000 x g for 30 min in a 70.1 Ti rotor (Beckman
Instruments, Inc.). The supernatant was carefully removed
and made 6% in TCA, and the centrifugation pellet was
resuspended in 6% TCA. Both TCA precipitations were held
on ice for 20 min and then centrifuged at 13,000 x g for 2
min. The TCA pellets were washed twice with acetone,
dried, and resuspended in 150 ,ul of boiling buffer (50 mM
Tris hydrochloride [pH 7.5], 1 mM EDTA, 1% SDS). The
samples were then immunoprecipitated as described above.
Labeling of cells with fluorescent dyes. Yeast cells were
labeled with fluorescein isothiocyanate (FITC) and
CDCFDA as previously described (3, 34) except that when
FITC was used, the cells were washed with solutions con-
taining 2% glucose. The ade2 endogenous fluorophore was
visualized in stationary-phase yeast cells grown either in
YPD medium or in adenine-limiting medium, as previously
described (53). Microscopy and photography were done as
previously described (3).
Nucleotide sequence accession number. The GenBank ac-
cession number for the sequence reported is X53531.
RESULTS
Cloning and characterization of the VPS34 locus. The
VPS34 gene was cloned by complementation of the recessive
temperature-sensitive growth defect associated with the
vps34-2 allele. SEY34-2 cells (vps34-2 ura3-52; Table 1) were
transformed with a yeast genomic library constructed in the
YCpSO centromere-containing plasmid (37). Approximately
20,000 Ura+ transformants were selected at 26°C on minimal
plates lacking uracil. After 3 days at 26°C, the transformants
were replicated onto prewarmed YPD plates and incubated
at 37°C. Temperature-resistant colonies were picked, and
the plasmid DNA was isolated. After amplification in E. coli,
the plasmids were reintroduced into SEY34-2 to retest their
complementing activity. Only one plasmid, pPHY34, was
able to confer a temperature-resistant phenotype upon the
cells (Fig. 1). This plasmid also complements the tempera-
ture-sensitive defect associated with the vps34-6 allele (data
not shown).
We also tested the ability of pPHY34 to complement the
other phenotypes associated with vps34 mutants. vps34 cells
have previously been shown to be sensitive to osmotic stress
(3), as demonstrated by their inability to grow on solid media
containing 1.5 M NaCl (Fig. 1). The cloned DNA was able to
fully complement the osmotic sensitivity phenotype of vps34
mutants (Fig. 1).
The cloned DNA was also able to complement the vacu-
olar protein sorting defects associated with vps34 mutations.
We directly analyzed the localization of CPY in yeast cells
by labeling intact spheroplasts with [35S]methionine and
[35S]cysteine, fractionating the cultures into supernatant
(extracellular) and pellet (intracellular) fractions, and then
immunoprecipitating the cultures with antiserum to CPY.
The spheroplasts were labeled for 20 min and then chased for
an additional 30 min. In wild-type yeast cells, >95% of the
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FIG. 1. Ability of plasmid pPHY34 to fully complement the growth defects associated with the vps34-2 allele. The following strains were
streaked out onto either 26°C YPD, 37°C YPD, or 26°C YPD-1.5 M NaCl plates and incubated for 2 to 6 days: SEY6210 (wild type), PHY102
(Avps34), SEY34-2 (vps34-2), and SEY34-2 harboring plasmid pPHY34 [vps34-2(pPHY34)].
newly synthesized CPY was present as a 61-kDa mature
species in an intracellular fraction (Fig. 2). In contrast, in
vps34-2 cells, <5% of the CPY was present as a mature
species. The majority of the CPY was present as the Golgi-
modified 69-kDa (p2) precursor molecule, and more than
90% of this p2 CPY was secreted by the mutant cells (similar
to results for the Avps34 mutant in Fig. 2). Therefore,
vps34-2 mutants exhibited severe defects in the localization
of CPY. The introduction of plasmid pPHY34 into vps34-2
mutants corrected this sorting defect (data not shown; see
Fig. 2). The genomic DNA present within plasmid pPHY34
was therefore capable of complementing all vps34 mutant
phenotypes examined.
Restriction enzyme mapping demonstrated that this com-
plementing plasmid, pPHY34, contained a genomic DNA
insert of -8 kb (Fig. 3A). Various restriction fragments were
subcloned into the yeast single-copy vector, pPHYC18, and
were subsequently tested for complementing activity (Fig.
3A). This analysis localized the complementing activity to a
4.1-kb ClaI-KpnI fragment. To more precisely define the
limits of the VPS34 functional unit, we performed exonucle-
ase III-mung bean nuclease deletions upon this ClaI-KpnI
fS34 A i). !4 (NE 2_
I e I i,' I l, X
1.) 5 Ci\
_-+
FIG. 2. Intracellular sorting of CPY. Yeast spheroplasts were
radiolabeled with Tran 3IS label for 20 min at 30°C and then chased
for 30 min at 30°C following the addition of cold methionine and
cysteine to 2 mM. The labeled cultures were centrifuged for 2 min at
13,000 x g and separated into a pellet (I, intracellular) and a
supernatant (E, external) fraction. The level of CPY in each fraction
was assessed by quantitative immunoprecipitation with antiserum to
CPY. The strains examined were SEY6210 (VPS34), PHY102
(Avps34), PHY102 harboring the pPHY34 plasmid (VPS34 CEN),
and SEY6210 harboring the multicopy VPS34 plasmid pPHY52
(VPS34 2,u). The positions of mature CPY (mCPY; 61 kDa) and p2
CPY (69 kDa) are indicated.
fragment. Deletions of as little as 200 bp from the KpnI side
resulted in a loss of complementing activity. However, we
found that as much as 1,200 bp could be removed from the
ClaI side without any detectable loss of function. The final
fragment shown in Fig. 3A represents the smallest DNA
fragment found to possess VPS34 complementing activity.
To determine whether the pPHY34 complementing activ-
ity represented the authentic VPS34 locus, we assessed the
genetic linkage between the cloned genomic DNA and the
vps34-2 allele. The 3.4-kb BamHI-SacI fragment ofpPHY34
was subcloned into a TRPI yeast integrating plasmid,
pPHYI10. The resultant plasmid, pPHY35, was digested
with XhoI to direct its integration to the chromosomal
homolog of the cloned DNA (41). This digested DNA was
transformed into the yeast strain SEY6211, and Trp+ trans-
formants were selected and mated to SEY34-2. The resultant
diploid was induced to sporulate, and the meiotic progeny
were analyzed by standard tetrad analysis. If the cloned
DNA represented the true VPS34 locus, then the Trp+ and
Ts' phenotypes would be expected to cosegregate. In all 20
tetrads analyzed, a 2 Trp+ Ts+:2 Trp- Ts- segregation
pattern was observed. These results indicate that the com-
plementing DNA within pPHY34 originated from a region of
the yeast genome that is homologous to the VPS34 gene.
RNA transcripts from the VPS34 locus were identified by
probing Northern blots of yeast RNA with single-stranded
RNA probes prepared from either strand of the VPS34
clone. A single poly(A)+ RNA of approximately 2,800 nu-
cleotides was detected from this locus (Fig. 3B). The direc-
tion of transcription was determined to be from the BamHI
site toward the XhoI site (Fig. 3).
DNA sequencing and sequence analysis. The VPS34 mini-
mum complementing fragment (Fig. 3A) was sequenced by
using standard dideoxy-chain termination methods as de-
scribed in Materials and Methods. The DNA sequence
identifies an open reading frame of 2,625 bp which has the
potential to encode a protein of 875 amino acids (Fig. 4A).
Upstream of the initiation codon, at position -120, there is
a TATA-like sequence element, TATAT, which closely
resembles the consensus TATAAA yeast sequence (Fig. 4A;
49). A sequence, TAGT. ...TAG.. .lTTT, which closely
approximates the proposed yeast transcription termination
consensus signal, was identified 86 nucleotides downstream
MOL. CELL. BIOL.
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FIG. 3. (A) Restriction enzyme map of the -8-kb genomic DNA insert in plasmid pPHY34. The VPS34 coding region and direction of
transcription are indicated by the heavy arrow. Restriction enzyme abbreviations: ClaI (C), BamHI (B), XhoI (X), KpnI (K), Sacl (Sc), PvuII
(P), and Sall (S). Specific restriction fragments or exonuclease III-mung bean deletions were subcloned into pPHYC18 and transformed into
SEY34-2. A plus sign indicates that the fragment was able to complement the vps34-2 temperature-sensitive growth defect. ORF, open reading
frame. (B) Identification of the VPS34 RNA transcript by Northern blot analysis. Poly(A)+ RNA (5 ,ug) was run out on formaldehyde-1%
agarose gels, transferred to GeneScreen membranes, and probed with antisense (I) or sense (II) VPS34 [3P]RNA made with either T7 or T3
RNA polymerase from plasmid pPHY34.17.
from the stop codon (Fig. 4A; 56). The predicted open
reading frame is terminated by a single UGA codon, and its
size is in good agreement with that of the single 2.8-kb
poly(A)+ RNA detected from this region. The deduced
protein sequence indicates that Vps34p is relatively hydro-
philic and possesses 10 potential sites for N-linked glycosyl
modification. A hydropathy analysis of this sequence sug-
gests the absence of an N-terminal signal sequence or any
potential membrane-spanning domains within this protein
(Fig. 4B). A comparison of the predicted protein sequence
with those in the GenBank and NBRF data bases failed to
reveal any sequence similarities of obvious significance (24,
31).
Deletion-disruption of the VPS34 gene results in a temper-
ature-sensitive growth defect. To examine the phenotypic
consequences of a null allele of VPS34, we constructed a
gene deletion-disruption of this locus by using plasmid
pPHY38. This plasmid contains a copy of the VPS34 gene in
which the 1.0-kb BamHI-XhoI fragment has been replaced
with the yeast TRPI gene (Fig. 5A). Following linearization,
this DNA was used to transform the diploid strain
SEY6210.5 to tryptophan prototrophy by replacing one
wild-type copy of VPS34 with the disrupted allele through
homologous recombination. Two independent Trp+ trans-
formants were placed on sporulation medium, and their
resultant progeny were subjected to tetrad analysis. In all 19
tetrads examined, the Trp phenotype was observed to seg-
regate 2 Trp+:2 Trp-, as expected for a single replacement
event. As this result implies, all four haploid progeny,
including the disrupted (or Trp+) haploid strains, were viable
at 26°C, and therefore VPS34 is not an essential yeast locus.
Because we had previously isolated recessive temperature-
sensitive alleles of the VPS34 locus (36), we examined the
growth of the aforementioned meiotic progeny at 37°C. We
found that all tetrads displayed a 2 Trp+ Ts-:2 Trp- Ts'
segregation pattern, indicating that our gene disruption of
the VPS34 locus results in a temperature-sensitive growth
defect. This finding implies that the VPS34 gene product is
essential for growth only at elevated growth temperatures.
The construction of a VPS34 gene disruption in the haploid
yeast strains SEY6210 and SEY6211 also resulted in a
temperature-sensitive growth defect (Fig. 1). The Avps34
strains were observed to arrest at the one- to two-cell stage
following a shift to 37°C. Avps34 cells that had been arrested
for 3 h at 37°C did not assume a uniform arrest morphology
(data not shown). At 26°C, the generation time of Avps34
mutants is approximately 1.5 to 2 times that of an isogenic
wild-type strain.
We verified the genomic structure of the vps34AJ:::TRPJ
alleles with an application of PCR DNA amplification meth-
ods (42, 43). Yeast cells were lysed with glass beads and
centrifuged for 2 min at 13,000 x g. An aliquot of this
clarified lysate corresponding to 0.01 OD6. cell equivalents
was used for the PCR analysis. Each DNA template was
mixed with a set of three 25-mer oligonucleotide primers that
hybridize to specific regions of either the VPS34 gene or the
TRPJ locus (Fig. 5A). The primers were chosen such that the
wild-type VPS34 gene would produce a single PCR product
of 900 bp from primers 1 and 2 and the vps34AJ:: TRPI allele
would result in a single 1,100-bp PCR product from primers
1 and 3 (Fig. SA). When SEY6210 lysates, containing the
wild-type VPS34 gene, were used as the template, the
predicted 900-bp PCR product was observed (Fig. 5B). The
heterozygous diploid, PHY120 (VPS341vps34AJ :: TRPI),
produced the expected doublet of 900 and 1,100 bp (Fig. SB).
Genomic DNA from four haploid progeny of a single
PHY120 meiosis were also analyzed, and the results ob-
tained are consistent with the genetic analysis of these
strains (Fig. SB). Further confirmation of the identity of the
VPS34 allele(s) present was obtained by restriction of the
PCR products with either BamHI or HindIlI (Fig. SA). The
restriction enzyme BamHI specifically cut the 900-bp PCR
product of the wild-type gene into 600- and 300-bp fragments
and did not digest the products from the disruption allele
(data not shown). Conversely, HindIII restriction resulted in
the production of a 600- and a 500-bp fragment from the
1,100-bp disruption allele product without affecting the
900-bp fragment (data not shown). Therefore, this PCR
technique allows for a rapid (less than 6 h), nonisotopic, and
precise analysis of the genomic DNA at the VPS34 locus.
As expected, the Avps34 cells exhibited an extreme vac-
uolar protein sorting defect, mislocalizing >95% of its CPY
to the cell surface in a p2 precursor form (Fig. 2). The
presence of the wild-type VPS34 gene on a CEN-containing
plasmid completely corrected this sorting defect (Fig. 2). As
with the original temperature-sensitive alleles (36), the CPY
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1 AAA AGGTATTCTT 13
14 TGAGTGAATT GTAGATGTCT GAGCGTTTGC GCTGAGGGTT TTATAOGATG TGTCATTTCC TTOAGAGCAG AOGCATAAGT GCTAAAGCAT TGT0XXTAC AGACA.TTGAA GTTIOTGCAT 133
134 ACGGACTGGC GAATACACCT COAkCATGGGG CTGAAGCTTT CGACA)ATCT TAAATTGTA CTTMT(TCAT GAAATTTTTA TATGkAAGGTT TTAAATAAGT GGAkCATAGTC CTTCATTOGG 253
254 TATATCAGA TCCGCATOA AAGACTTTTT CAAGAAAGTT TGAGTCAAAA GGATTAAAGG ATAAAGTAAA ACA.ACAATAA CATCTOGGTG AAGCATTGAkG OGGAGGGTTT AAGCCAkACA 373
374 ATG TCA CTG AAC AAC ATA ACA TTC TOGT GTC TCA CAG OAT CMO GAT GTT COG CTG AAA GMO AMA AC AAG TCA TTG GMA GGAk CAT MAG CCA CTG TTG AAG CCA TCT CAA 481
1 Met Ser Lou Asn Asn Ile Thr Ph. Cys Val Ser Gin Asp Lou Asp Vai Pro Lou Lys Vai Lys Ile Lys Ser Lou Glu Gly His Lys Pro Lou Lou Lys Pro Sor Gin 36
482 AAA ATC CMO AAC CCT GMA TTA ATG CTG ATA GOG TCA MAT GTA TTC CCT TCT AGT GAT CTA ATT GTA TOG TTA CAG GTA TTT GAT MAA GAG AGA MAC AGA MAT TTA ACT 589
37 Lys Ilie Lou Asn Pro Glu Lou Met Lou Ile Gly Ser Asn Vai Ph. Pro Sor Sor Asp Lou Ilie Vai Ser Lou Gin Val Ph. Asp Lys Glu Arg Asn ArN Asn Lou Thr 72
590 CTT COG ATA TAG ACG COG TAT ATT CCT TTC AGA AAC TCT AGA ACC TOG GAT TAT TOG TTG ACT TTM COG ATA CGT ATC AMA CAG CTT ACC TTT AOGC ACT CAT TTA COG 697
73 Lou Pro Ile Tyr Tb' Pro Tyr Ile Pro Ph. Arg Asn Ser ArN Tb' Tip Asp Tyr Tip Lou Tb' Lou Pro Ile Arg Ile Lys Gin Lou Tb' Ph. Ser Ser His Lou ANg 108
698 ATT ATT TTG TOG GMA TAG MAT GGA TOG MAG CMA ATT COG TTT TTC MAT CTA GMA AOG AGC AlC TTT AAC TTA AMA GAG TGT ACT TTA AMA AGA GOG TTT GMA TOG TTA 8G5
109 Ile Ilie Lou Tip Glu Tyr Asn Giy Ser Lys Gin Ile Pro Ph. Ph. Asn Lou Glu Thr Ser Ile Ph. Asn Lou Lys Asp Cys Thr Lou Lys ANg Gly Ph. Glu Sor Lou 144
806 AMA TTT COT TAT CAT GTG ATT GAG CAG TOT GMA GMO GTC ACT CAT AAC AMA CAT CMA GMA MAT TTG MAT AMA TAT TTT CAG GOT GMA TIC AOG AGCA CTC CCT TOG CTT 913
145 Lys Ph. ANg Tyr Asp Vai Ile Asp His Cys Glu Vai Val Thr Asp Asn Lys Asp Gin Giu Asn Lou Asn Lys Tyr Ph. Gin Gly Giu Ph. Thr ANg Lou Pro Tip Lou 180
914 GAG GMA ATC ACT ATA AOC AMA TTA AOG AMA CMA COG GMA MAT AOG ACT TOG CCT CAG GOG AOG TTT GTC TTA MAC TTA GMA TTT CCA ATG TTA GAG CTT CCT GTT GTO 1021
181 Asp Giu Ilie Tb' Ilie Ser Lys Lou ANg Lys Gin ANg Giu Asn ANg Thr Tip Pro Gin Giy Thr Ph. Vai Lou Asn Lou Giu Phe Pro Met Lou Giu Lou Pro Vai Vai 216
1022 TTC ATC GMA AOG GMA ATT AM MAT ACT CMA ATO MAT ATT CCA ACT TTG MAG AAC MT CCT GGA CTA AOC ACA GAG TTA CGA GMA COG MAT AOG MAT CAT CCT CMA ATC 1129
217 Phu Ilie Giu ANg Giu Ilie Met Asn Thr Gin Met Asn Ilie Pro Thr Lou Lys Asn Asn Pro Giy Lou Sor Thr Asp Lou ANg Giu Pro Asn ANg Asn Asp Pro Gin Ile 252
1130 AMA ATT TCT TTG GOG GAG AMA TAT CAG TOG ACA TTG MAG TTT TACGCAT CCT GAG CMA CCA AAC MAT CAT CCA ATA GAG GMA MAG TAT AOG ACA TTG GMA ACA GCA TCT 1237
253 Lys Ilie Ser Lou Gly Asp Lys Tyr His Sor Thr Lou Lys Ph. Tyr Asp Pro Asp Gin Pro Asn Asn Asp Pro Ile Giu Giu Lys Tyr ANg ANg Lou Glu ANg Ala Ser 288
1238 AMA MAT GCA MAC TTG GAG MAG CMAOTO MAG COG GAG ATT AMA MAG AOG GAG TAG TTG MAT AMA ATC ATC MAC TAG COG CCT GOGC ACT AMA TTA ACA GCA CAT GMA MAG 1345
289 Lys Asn Ala Asn Lou Asp Lys Gin Vai Lys Pro Asp Ile Lys Lys ANg Asp Tyr Lou Asn Lys Ile Ile Asn Tyr Pro Pro Giy Tb' Lys Lou Tb' Aia His Glu Lys 324
1346 GOT TCA ATA TOG AMA TAT AOG TAT TAT TTG ATG MAC MAT AMA AMA OCT CTT ACA MAG TTA TTA CAG AOT ACA MAT TTG AGA GMA GMA TOG GMA ACA GTA GAG OTT TTA 1453
325 Gly Ser Ilie Tip Lys Tyr ANy Tyr Tyr Lou Met Asn Asn Lys Lys Ala Lou Thr Lys Lou Lou Gin Ser Thr Asn Lou ANg Glu Giu Ser Giu ANg Vai Glu Val Lou 360
1454 GMA CTA ATM GAG TCA TOG GCA GMA ATT CAT ATA GAG GACGOCA TTA GAA CTA TTA GOG TCA ACT TTT AMA MAC CTT TCA GTG AGA TOG TAG GO GOTA MAT AOG CM MAG i561
361 Glu Lou Met Asp Ser Tip Ala Glu Ilie Asp Ile Asp Asp Aia Lou Glu Lou Lou Gly Ser Thr Phe Lys Asn Lou Ser Val ANg Ser Tyr Ala Vai Asn ANg Lou Lys 396
1562 MAG GCA TCA GAG MAG GAG CTM GMA TM TAG TTA TTA CAG TTG GTA GMA OCT GTIC TOT TTT GAG MAC CTO TOG ACT TTT TOG GAG AMA TCT MAC AOT GMA TTC ACT ATT 1669
397 Lys Ala Ser Asp Lys Glu Lou Glu Lou Tyr Lou Lou Gin Lou Vai Glu Ala Val Cys Ph. Glu Asn Lou Ser Thr Ph. Ser Asp Lys Ser Asn Ser Glu Ph. Tb' Ile 432
1670 GTOG CAT GOCGOTA TOT TOG CMA MOG CTT TOG GOT CAT TCT AMt TTA CTA TCT ACA TOG CAT GCC MAC CMA AMA TTA TTA MAG TOG ATO TOG AOT GMA TOG GMA ACT TOG 1777
433 Vai Asp Ala Vai Ser Ser Gin Lys Lou Ser Gly Asp Ser Met Lou Lou Ser Thr Ser His Ala Asn Gin Lys Lou Lou Lys Ser Ilie Ser Ser Glu Ser Glu Tb' Ser 468
1778 GOG ACA GMA TOG CTA CCA ATC GTIC ATT TCT COG TMO OCT GAG TTT TMO ATT AOG ACA GCA CTG GTC MAC CCA AOG TTA GGA AOT TTT TlTC TAT TOG TAT TTA MAG TOG 1885
469 Gly Thr Glu Ser Lou Pro Ilie Vai Ilie Sbr Pro Lou Aua Glu Ph. Lou Ilie ANg ANg Ala Lou Vai Asn Pro ANg Lou Gly Ser Ph. Ph. Tyr Tip Tyr Lou Lys Seor 504
1886 GAG TCT GAO GAG MAG CCA TAT TTA GAG CAG ATT TTA AGT TOG TTT TOGl ACT ACA CMt CAT AMA AMA TCT COG MAT ATA CTG MAC CAT CMA GTC AOG CTA ATA MAT GOTO 1993
505 Glu Ser Glu Asp Lys Pro Tyr Lou Asp Gin Ilie Lou Ser Ser Ph. Tip Sbr ANg Lou Asp Lys Lys Set ANg Asn Ilie Lou Asn Asp Gin Val ANg Lou Ilie Asn Val 54051.5
1994 CTC AOG GMA TOT TOT GMA ACA ATT AAG AOG CTIG AMA CAT ACT ACA 0CC AMA MAG Alt. GAA TTA CTA OGM CAT TTA Till GAG AOG AMA GltC AOG CCT CTT GIt AMA GTA 2101
541 Lou ANg Glu Cys Cys Glu Thr Ilie Lys ANg Lou Lys Asp Thr Thr Ala Lys Lys Met Giu Lou Lou Vai His Lou Lou Glu Thr Lys Val ANg Pro Lou Val Lys Val 576
2102 CGA CCA ATT OCT TTA CCA CTA GAG CCT CAT GTG TTOG ATA TOG GACGOTT TOT CCT GMA ACT TOG AAG GTA TTT AMA AOG TOT TTA TOG CCA CTA AMA ATA ACA Tlt AMA 2209
577 ANg Pro Ilie Ala Lou Pro Lou Asp Pro Asp Vai Lou Ilie Cys Asp Vai Cys Pro Glu Thr Ser Lys Vai Ph. Lys Ser Ser Lou Sor Pro Lou Lys Ilie Thr Ph. Lys 612
2210 AOG ACC TTA MAC CMA CCA TAT CAG TTA AMt TTT AAO OTT GOCGCAT OAT TMl ACA CMA CAT CMA CtG GTA GTA CAG Alt ATA AOT TTA AM MAT GAG TTA TTA AMA MAT 2317
613 Thr Thr Lou Asn Gin Pro Tyr His Lou Met Ph. Lys Val Gly Asp Asp Lou ANg Gin Asp Gin Lou Vai Vai Gin Ile Ile Ser Lou Met Asn Glu Lou Lou Lys Asn 648
2318 GMA MAC GTG GAG TTO AMA TTO ACA CCA TAG AMA ATT TMO GCA ACA GGA CCA CMA GMA GOT GOG ATT GMA TTT AlT CCT MAT GAC ACA TTA OCT AOG ATA CTA AOG AMA 2425
649 Glu Asn Vii Asp Lou Lys Lou Thr Pro Tyr Lys Ilie Lou Ala Thr Gly Pro Gin Glu Gly Ala Ile Glu Ph. Ilie Pro Asn Asp Thr Lou Ala Ser Ilie Lou Ser Lys 684
2426 TAT CAG GOT ATT CTT GOG TAG CTT AMA CltC CAG TAT CCT CAT GAO MAC GOG ACA TTA GOGC GTA CMA GOGC TOG OTT TTA CAT MAT TTT GTC AMA TCT TOT OCT GOGC TAT 2533
685 Tyr His Gly Ilie Lou Gly Tyr Lou Lys Lou His Tyr Pro Asp Glu Asn Ala Thr Lou Gly Vai Gin Gly Tip Vai Lou Asp Asn Ph. Vai Lys Ser Cys Ala Gly Tyr 720
2534 TOT OTT ATT ACA TAG Alt TTA GOT GltC GOGC CAT ACTG CAT TTA GAG MAC TTA CTA Olt AOG CCA CAT GOG CAG TTT TTT CA GOCA GAG TTT GOT TAT Alt TTM GOT CAG 2641
721 Cys Vii Ilie Thr Tyr Ilie Lou Giy Vai Giy Asp ANg His Lou Asp Asn Lou Lou Vai Thr Pro Asp Gly His Ph. Ph. His Ala Asp Ph. Gly Tyr Ile Lou Gly Gin 756
2642 GAG COG AMA CCT TTT COG CCA TTA AltG AMA TTO. CCC CCT CMA ATT ATA GAG GOG TTT GOG GOT GCA GMA TCA TCA MAT TAT CAT AMA TTT COGC AOGC TAG TOT TTT GltG 2749
757 Asp Pro Lys Pro Ph. Pro Pro Lou Met Lys Lou Pro Pro Gin Ilie Ilie Giu Ala Ph. Gly Gly Ala Glu Ser Ser Asn Tyr Asp Lys Ph. ANg Ser Tyr Cys Ph. Vai 792
2750 GCA TAT TOG ATT TTA AGA AOG MAT GCA GOG TTA AlT TTA MAC CItG TTT GMA TTA AltG MAG ACT TOG MAC ATA CCT CAT AlTC AGA ATA CAT COG MAT GOT OCT ATA TTA 2857
793 Ala Tyr Sbr Ilie Lou ANr ANg Asn Ala Gly Lou Ilie Lou Asn Lou Ph. Giu Lou Met Lys Thr Ser Asn Ilie Pro Asp Ilie AN Ilie Asp Pro Asn Gly Ala Ilie Lou 828
2858 COT GTA ACA GAO ACA TTT MAT TTO MAT AlTG TOG GMA GMA CAT GCC ACA OGM CAT TTT CAG MAT CTA AltC MAT CAT ACT GTA MAT OCT TTG CtG CCT AltC OltG ATT CAT 2965
829 ANg Vii ANg Glu ANg Ph. Asn Lou Asn Met Sbr Glu Giu Asp Ala Thr Vii His Ph. Gin Asn Lou Ilie Asn Asp Sbr Vii Asn Ala Lou Lou Pro Ilie Vii Ilie Asp 864
2966 CAT TTA CAT MAT CTOG GCA CMA TAC GTOCGG AGC TOGA 3001
865 His Lou His Asn Lou Ala Gin Tyr Tip Arq Thr End 875
KpnI 5 5
3002 TTOGTTGATA ATTOGGTOGTT CAAAATTTMA ATTTOGTOCAG TCTMATTATA CTTAACATAT AMATGGTAOC TTCMATATAT CTTC7TIaZA AAAAGIWCA TOAT=TT G TTMATTTOGCA 3121
3122 CTTTTTTTAT TTAAAAMTMA AAMTOAGAGT TMATTTTTCA TGATCTTOGA MGAGACAGOGC TOGCGCTMAT GTOGGATATA TMACMATTOT GAATCAGAMA AACTOMACAC TTTMACATMA 3241
3242 TGOGOGGAGA GAAOGCTAAA CAAACMAGAT TAOGCATTOGA 3280
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FIG. 4. (A) Nucleotide sequence of the VPS34 locus. The DNA sequence of the VPS34 coding strand and the predicted primary sequence
of its product are shown. The positions of important restriction enzyme sites are indicated above their respective recognition sequences.
Potential transcriptional initiation and termination signals are indicated with asterisks. (B) Hydropathy analysis of Vps34p. The predicted
amino acid sequence of the VPS34 gene product was subjected to a hydropathy analysis by the method of Kyte and Doolittle (23). A scanning
window of 11 amino acids was used. Hydrophobic values lie above the horizontal axis; hydrophilic values lie below. The amino acids are
numbered along the horizontal axis.
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FIG. 5. (A) Construction of a gene disruption at the VPS34 locus and verification of the resulting genomic structures. The 1.0-kb
BamHI-XhoI fragment of the VPS34 gene was replaced by the yeast TRPI gene as described in Materials and Methods. The genomic structure
at the VPS34 genetic locus was analyzed by PCR DNA amplification. Three 25-mer primers were added to the genomic DNA template, and
30 cycles of amplification with TaqI polymerase were performed. If the wild-type (wt) VPS34 gene is present, an amplification product of -900
bp is produced with primers 1 and 2. The presence of the vps34AJ::TRPJ allele results in the appearance of a DNA fragment of -1,100 bp
from primers 1 and 3. The heavy black arrows indicate VPS34 coding sequence, and the large stippled arrow represents the TRPI coding
region. (B) Analysis of the PCR products by agarose gel electrophoresis. The PCR products were run out on 1.2% agarose gels, stained with
ethidium bromide, and then photographed. The genomic DNA analyzed was obtained from yeast as follows: Dp indicates the diploid strain
PHY120; A, B, C, and D indicate the four haploid progeny from a single PHY120 meiosis; and wt refers to SEY6210. The A reaction mix
contained -0.5 ng of pPHY38 plasmid DNA. Genetic analysis of the PHY120 progeny indicated that A and B were wild type at the VPS34
locus and C and D were mutant (growth at 37°C and CPY localization were assessed; data not shown). The positions of the 900- and 1,100-bp
products are indicated. (C) Analysis by Nomarski optics and epifluorescence. No intracellular ade2 fluorescence is detected within PHY103
cells (vps34AJ::TRP1 ade2). Yeast cells were grown to stationary phase in YPD medium, mounted for microscopy, and then examined by
either Nomarski interference optics (left) or epifluorescence (right). The top panels show SEY6210 (VPS34) cells, and the bottom panels show
PHY103 (vps34A1::TRP1). Bar, 20 ,um.
missorting phenotype was equivalent at both the permissive
and nonpermissive growth temperatures in the Avps34
strains (data not shown). As well, Avps34 yeast cells were
observed to be osmotically sensitive, as illustrated by their
lack of growth on medium supplemented with 1.5 M NaCl
(Fig. 1).
The disruption allele of VPS34 resulted in one additional
phenotype not seen with any other vps34 allele. Normally,
ade2 yeast colonies turn red on adenine-limiting media. This
coloring is apparently due to the accumulation of a naturally
fluorescent metabolic intermediate of adenine biosynthesis
in the vacuolar compartment (17, 47, 53). Therefore, the
vacuoles of ade2 yeast cells are fluorescent and easily
visualized by light microscopy (53). When Avps34 ade2
double mutants were placed on adenine-limiting medium, the
colonies remained white (as do ADE2 colonies). By intro-
ducing the wild-type VPS34 gene back into these mutants,
they regained the red ade2 phenotype, demonstrating that
the ade2-white phenotype was a direct consequence of the
vps34AJ::TRPI allele. This defect was also apparent at the
cellular level. Whereas the vacuoles of SEY6211 (ade2
VPS34) were strongly fluorescent, Avps34 ade2 cells exhib-
ited no significant intracellular fluorescence (Fig. 5C). A
similar ade2-white phenotype was observed with the class C
vps mutants (3). These mutants apparently lack a normal
vacuolar compartment, and the absence of ade2 fluores-
cence may be due to the lack of a compartment in which to
sequester this metabolic intermediate of adenine biosynthe-
sis. In contrast, Avps34 cells do possess a detectable vacu-
olelike intracellular organelle (see Nomarski photographs,
Fig. SC). These organelles, like wild-type vacuoles, are able
to accumulate fluorescent dyes specific for the vacuole, such
as FITC and CDCFDA (see below). It is interesting that the
two spontaneously isolated temperature-sensitive alleles of
VPS34 result in an intermediate ade2 phenotype (pink),
suggesting that these two alleles retain residual VPS34 gene
function.
Diploid strains homozygous for the vps34AJ ::TRPI allele
sporulated with a much lower efficiency than did wild-type
diploids or those that were heterozygous at the VPS34 locus
(data not shown). A similar sporulation-deficient phenotype
has been observed with pep4/pep4 diploid strains (50, 57),
suggesting that the sporulation defects of Avps34 diploids
may be due to the decreased levels of PrA enzymatic activity
associated with these mutants (data not shown; 36).
Identification and characterization of Vps34p. To charac-
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FIG. 6. Identification and characterization of Vps34p. Yeast
strains were labeled with Tran 35S label in YNB-glucose minimal
medium for 30 min at 30°C. The cells were broken, and immunopre-
cipitations were performed from the clarified cell lysates with either
the preimmune control serum (P) or the Vps34p immune serum (I).
Copy number refers to the gene dosage of VPS34; A is PHY102 (no
copies), L is SEY6210 (one copy), and H is SEY6210 with plasmid
pPHY52 (multiple copies). The PHY102 and SEY6210 immunopre-
cipitations were performed from eight OD6w equivalents of cells
instead of two (see Materials and Methods). Where indicated (+),
the cells were treated with tunicamycin (20 ,ug/ml) for 15 min prior
to labeling. The labeled cultures were chased with cold methionine
and cysteine (final concentration, 2 mM) for the indicated times. The
position of Vps34p is indicated (95,000 Da).
terize the VPS34 gene product, we prepared polyclonal
antisera against a TrpE-Vps34 fusion protein isolated from
E. coli (see Materials and Methods). This fusion protein
consisted of amino acids 125 to 462 of Vps34p fused in frame
to the C terminus of the E. coli trpE protein. Upon induction
with indoleacrylic acid, an artificial inducer of the trp op-
eron, E. coli cells carrying this trpE-VPS34 fusion gene
produced a novel protein of 74-kDa at a relatively high level
(-10% of total cell protein). This hybrid protein was purified
and used to immunize rabbits. The resulting polyclonal
antiserum was used in quantitative immunoprecipitations
from radiolabeled yeast extracts. This antiserum detected a
unique polypeptide of an apparent molecular weight of
-95,000 from wild-type yeast cells (Fig. 6). This relatively
rare yeast protein was not immunoprecipitated by the pre-
immune control serum and was not detected in Avps34 cell
extracts (Fig. 6). In addition the presence of a multicopy
VPS34 plasmid resulted in an approximately 30 to 50-fold
increase in the level of this 95-kDa polypeptide (Fig. 6).
These data indicate that the polyclonal antiserum specifically
recognizes the protein product of the VPS34 gene. Densito-
metric analysis of the levels of Vps34p relative to CPY
(-0.1% of total cell protein) suggested that Vps34p com-
prises <0.01% of total cell protein in logarithmically growing
yeast cultures. It is interesting that the overproduction of
Vps34p did not result in a vacuolar protein sorting defect
(Fig. 3).
The predicted sequence of Vps34p indicates that this
protein contains 10 potential sites for N-linked glycosyl
modification. However, the apparent absence of any poten-
tial N-terminal signal sequence, or other membrane-span-
ning domains, suggests that this protein does not enter the
secretory pathway. To directly test this prediction, we
treated yeast cells with the drug tunicamycin, a potent
FIG. 7. Subcellular fractionation of Vps34p. DKY6224 (Apep4)
cells harboring the VPS34 multicopy plasmid pPHY52 were sphero-
plasted, labeled with Tran 35S label, and osmotically lysed. The cell
lysates were then centrifuged at 100,000 x g for 30 min following
extraction with either 1% Triton X-100, 2 M urea, or 1 M NaCl for
10 min at 0°C. The relative levels of Vps34p in the supernatant and
pellet fractions were assessed by quantitative immunoprecipitation
with antiserum to Vps34p. The values beneath the gel represent the
averages of three different experiments that examined the solubili-
zation properties of Vps34p, pl CPY, and phosphoglycerokinase
(PGK); the relative levels of each were determined by immunopre-
cipitation with the appropriate antisera. pl CPY is a marker for the
ER and early Golgi compartments, and phosphoglycerokinase is a
cytoplasmic protein.
inhibitor of N-linked glycosylation, prior to labeling and
immunoprecipitation. The Vps34p detected from tunicamy-
cin-treated cells was indistinguishable from the wild-type
protein on SDS-polyacrylamide gels, suggesting the absence
of asparagine-linked oligosaccharide modification (Fig. 6).
Pulse-chase experiments indicated that Vps34p was a rela-
tively stable protein species, with a half-life of at least 90 min
(Fig. 6). Therefore, Vps34p is a relatively rare, unglycosy-
lated protein of approximately 95,000 Da in molecular mass.
Subcellular fractionation of Vps34p suggests an association
with a multiprotein complex. The nucleotide sequence data
indicated that Vps34p is a relatively hydrophilic protein
lacking any potential transmembrane domains and therefore
might have a cytoplasmic localization. We used differential
centrifugation techniques to directly analyze the intracellular
location and associations of Vps34p. Yeast spheroplasts
were labeled for 30 min with [35S]methionine and [35S]
cysteine, osmotically lysed, and subjected to differential
centrifugations prior to quantitative immunoprecipitation
with antiserum to Vps34p. The osmotic lysis conditions were
chosen so that the integrity of specific internal organelles,
including the ER and Golgi compartments, was not dis-
turbed. Approximately 80% of the pl and p2 CPY, markers
for the ER and Golgi compartments (12, 48), was detected in
a 13,000 x g pellet fraction (Fig. 7; 10). In addition, more
than 90% of the mature CPY was released into a soluble
fraction, indicating that the vacuolar compartment was dis-
rupted by this lysis procedure (data not shown; 10).
The lysates of DKY6224 cells harboring the multicopy
VPS34 plasmid pPHY52 were centrifuged at 100,000 x g for
30 min, and the distribution of Vps34p between the super-
natant and pellet fractions was assessed. Approximately
50% of the Vps34p was present in the pellet fraction (Fig. 7).
The nature of the association of Vps34p with this particulate
fraction was analyzed by using several different extraction
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procedures. Following osmotic lysis, the cell lysates were
incubated with either 1% Triton X-100, 2 M urea, or 1 M
NaCl for 10 min at 4°C. The lysates were then centrifuged at
100,000 x g for 30 min, and the supematant and pellet
fractions were analyzed for the presence of Vps34p by
immunoprecipitation. Extraction with 1% Triton X-100 did
not significantly alter the distribution of Vps34p between the
two fractions; -50% of the Vps34p was still present in the
pellet fraction (Fig. 7). This Triton X-100 treatment was
sufficient to solubilize pl CPY (Fig. 7) and the integral
vacuolar membrane protein, alkaline phosphatase (data not
shown; 20). Treatment with 2 M urea readily solubilized
Vps34p from the particulate fraction (Fig. 7), suggesting that
Vps34p is associated with this pelletable structure through
protein-protein interactions. This urea extraction failed to
solubilize either pl CPY (Fig. 7) or alkaline phosphatase
(data not shown). The partial solubilization by a 1 M NaCl
extraction further suggests that the presence of Vps34p in
this complex is mediated by ionic interactions. We have
observed that -30% of this particulate Vps34p is present in
a 13,000 x g lower-speed pellet. The presence of Vps34p in
the particulate fraction was not the result of its overexpres-
sion in these experiments, as -40 to 50% of Vps34p was
detected in 100,000 x g pellet of DKY6224 cells expressing
wild-type levels of this protein (data not shown). This
particulate Vps34p was also solubilized by an extraction
with 2 M urea but not with 1% Triton X-100. Indirect
immunofluorescence experiments were performed with the
Vps34p-specific antiserum to localize the Vps34p within the
yeast cell. In wild-type cells, we observed a weak punctate
staining evenly distributed throughout the entire cytoplasm;
this signal was absent in Avps34 cells (data not shown).
Vacuole formation is delayed in Avps34 cells. A large
vacuolelike organelle was detected within Avps34 cells by
Nomarski optics, but this compartment did not accumulate
the endogenous ade2 fluorophore (Fig. 5C). To determine
the nature of this compartment, we labeled PHY103 yeast
cells (vps34AJ:: TRPI ade2) with two fluorescent dyes, FITC
and CDCFDA, which have been shown to accumulate
specifically within the vacuoles of wild-type yeast cells (3,
34, 53). The intracellular compartments within Avps34 cells
were specifically stained by both of these two fluorophores,
indicating that these structures are similar to wild-type
vacuoles (Fig. 8A and data not shown). However, within a
population, the vacuolar compartment visualized in Avps34
strains was a much more heterogeneous structure than that
observed in wild-type cells. Generally one to three large
FITC-staining compartments are detected within wild-type
cells (3, 33, 53). In Avps34 cells, the size of the FITC-staining
compartment varied greatly, with approximately 50 to 60%
of the population resembling wild-type cells (data not
shown). Approximately 5 to 10% of the Avps34 cells in a
logarithmically growing culture did not exhibit any FITC
fluorescence, a phenotype similar to that observed with the
class C vps mutants (3). The remaining -30%o of the Avps34
cells exhibited an intermediate morphology in which the
cells possessed multiple small staining compartments.
The most striking observation made with the Avps34
strains was that in general, no vacuolar compartment was
observed in newly forming cells. In wild-type cells, a vacu-
ole is detected in the newly forming bud when it is only a
fraction of the size of the mother cell (53). In Avps34 cells, no
vacuole, or only a very small compartment, was observed in
the newly forming bud by both FITC fluorescence and
Nomarski microscopy (Fig. 8A). A total of 45 budding cells
were observed at a time when the bud was greater than 50%o
A VWild type
Ax-ps34
` 'N.- -7.i.,- e ~
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FIG. 8. (A) Delay of vacuole formation in PHY103 cells
(vps34A1::TRPJ). Yeast cells were grown in YPD medium to early
log phase and were stained with the fluorescent dye FITC for 15 min
at room temperature. The cells were then mounted for microscopy
and examined by either Nomarski interference optics (left) or
epifluorescence (right). The top two rows show SEY6210 dividing
pairs (wild type), and the bottom four show PHY103 pairs (Avps34).
No FITC staining is detected in the buds of PHY103 cells. Bar, 10
,um. (B) Vacuolar assembly in yeast cells. A simple model depicting
two intracellular pathways contributing to vacuolar growth is
shown. Pathway 1 (inheritance pathway) represents the contribution
of the mother cell vacuole to the contents of the bud vacuole.
Pathway 2 (biosynthetic pathway) depicts the transport of newly
synthesized vacuolar constituents from the Golgi complex to the
vacuolar compartment(s). The contribution of endocytosis to vacu-
olar content and the potential delivery of vacuolar constituents from
the mother cell Golgi complex to the bud vacuole are not shown. See
text for further discussion.
the size of the mother cell. In 38 cases no FITC staining was
observed in the daughter bud, and in the 7 remaining dividing
pairs only a very small vacuole was detected in the bud. In
all cases but one, the mother cell possessed a normal
FITC-staining compartment (Fig. 8A). At a similar point in
the cell cycle, 28 of 30 wild-type buds examined were
observed to possess a relatively large vacuolar compartment
(Fig. 8A; 53). Identical results were obtained by staining the
dividing yeast cells with a second fluorescent dye, CDCFDA
(data not shown). In a logarithmically growing Avps34 yeast
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culture, the majority of the unbudded cells possessed a
vacuolar structure, as demonstrated by FITC fluorescence
microscopy. Therefore, these cells are competent for vacu-
ole assembly, but the data indicate that the formation of this
vacuolar compartment is delayed relative to that in wild-type
cells. In agreement with this view, in stationary-phase cul-
tures, in which cells arrest in G1 as unbudded cells, almost
all of the Avps34 cells possessed wild-type vacuolar struc-
tures (data not shown).
DISCUSSION
Mutations in the VPS34 gene result in severe defects in the
localization and processing of a number of vacuolar proteins.
To better understand the physiological role of the VPS34
gene product in this protein sorting process, we have cloned
and sequenced the wild-type VPS34 gene. In all, our studies
indicate that the VPS34 gene product is a hydrophilic protein
that may act as a component of a relatively large intracellular
complex to facilitate the delivery of vacuolar proteins. The
wild-type VPS34 gene was cloned by complementation of a
vps34 temperature-sensitive growth defect, and the VPS34
gene sequence identifies an open reading frame that could
encode a protein of 875 amino acids. The size of this open
reading frame is in good agreement with the RNA Northern
blot analysis and the protein data. The predicted protein
sequence indicates that Vps34p lacks any apparent N-termi-
nal signal sequence or other membrane-spanning domains,
suggesting that Vps34p is not a passenger of the secretory
pathway. Consistent with this prediction, immunoprecipita-
tion of cells labeled in the presence of tunicamycin indicates
that Vps34p contains no N-linked carbohydrate, even
though the predicted sequence possesses 10 potential sites
for such oligosaccharide modification. A comparison of the
Vps34p sequence with those in the GenBank and NBRF data
bases failed to reveal any significant homologies which might
have provided some clues into the biochemical nature of
Vps34p function.
Some insight into the possible function of Vps34p may be
provided by subcellular fractionation studies which indicate
that approximately 50% of the radiolabeled Vps34p associ-
ates with a particulate fraction of yeast cells. The solubility
properties of this particulate Vps34p suggest that protein-
protein interactions are responsible for the presence of
Vps34p in the pellet fraction. The failure of Triton X-100 to
solubilize Vps34p from this structure further suggests that
this protein is not simply associating as a peripheral protein
with a specific intracellular membrane. Instead, the fraction-
ation data are consistent with Vps34p being a component of
a relatively large multiprotein complex. This complex is
presumably functioning to facilitate a specific step(s) in the
vacuolar protein sorting process. Since only about 50% of
the Vps34p was detected within the pellet fraction, Vps34p
may exist in, and perhaps cycle between, two separate
intracellular pools. One interesting possibility, suggested by
the Triton X-100 fractionation data, is that Vps34p is asso-
ciated with the cytoskeletal network of yeast cells. In higher
eucaryotic cells, the cytoskeleton has been operationally
defined as the interconnected proteins that remain following
an extraction of the cells with nonionic detergents such as
Triton X-100 (5). Further biochemical studies are necessary
to determine the precise nature of the association of Vps34p
with this particulate fraction. We have initiated an analysis
of temperature-resistant suppressors of vps34(Ts) mutants in
an attempt to identify the specific cellular components which
interact with the Vps34p in vivo. The genetic analysis, in
combination with the biochemical studies, should lead to a
better understanding of the role of Vps34p in the delivery of
vacuolar proteins.
We constructed a gene disruption of VPS34 to assess the
phenotypic consequences of a null allele of this locus. The
structure of the disrupted allele in the genomic DNA was
verified by a rapid, nonisotopic PCR analysis (Fig. 5A and
B). Haploid yeast strains possessing the vps34A::TRPI
allele produced no detectable Vps34p and exhibited a severe
temperature-sensitive growth defect. Therefore, the VPS34
gene appears to be essential for vegetative growth only at
elevated growth temperatures. To our knowledge, the ob-
servation of a null allele exhibiting such a conditionally lethal
growth phenotype has been made only rarely in the litera-
ture. In S. cerevisiae, disruptions of two different genes,
both encoding products that might interact with actin, result
in conditional lethal phenotypes (13, 30). The biological basis
for the temperature-sensitive phenotype that we observe
with the vps34 null mutants is not known. The severity of the
vacuolar protein sorting defect was observed to be equiva-
lent at the permissive and nonpermissive growth tempera-
tures, at least for vacuolar delivery of CPY. It is possible
that more severe sorting defects, perhaps affecting additional
proteins, become apparent at the elevated growth tempera-
tures and result in the observed temperature-sensitive phe-
notype. The secretion of invertase, as well as other secreted
proteins, appears to be normal at the nonpermissive growth
temperature in vps34(Ts) mutants (36), suggesting that the
cessation of growth is not due to a block in general protein
secretion. It is possible that the vps34 sorting defects result
in a decrease in specific vacuolar activities that are required
for vegetative growth at this elevated temperature. The
proteins responsible for these activities may themselves be
mislocalized in vps34 mutant cells. Alternatively, the cumu-
lative stress of decreased vacuolar function plus the elevated
growth temperature may, in an additive fashion, result in the
observed inviability. In light of the rarity of conditionally
lethal null alleles, it is interesting that a similar temperature-
sensitive null phenotype has been observed for a number of
VPS genes, including VPSJ (39), ENDIIVPSII (9), VPSJ5
(P. Herman et al., submitted for publication), VPS33 (4), and
VPSJ6 (B. Horazdovsky, unpublished observations). Inter-
estingly, mutations in each of these genes result in defects in
vacuole assembly and an extreme sensitivity to osmotic
stress (3, 9). Altogether, these data might suggest a role for
the yeast vacuole in cellular responses to situations of
environmental stress, such as elevated growth temperatures
or osmotic stress. In cultured mammalian cells, the rate of
lysosomal degradation of certain cytoplasmic proteins has
been shown to specifically increase in response to cell
starvation (7). Clearly, more experimentation is necessary to
define the precise role of the vacuole in these stress re-
sponses.
The majority of the vps34 mutant cells possess a morpho-
logically normal vacuolar structure when analyzed with the
fluorescent dyes FITC and CDCFDA, both of which specif-
ically accumulate within the vacuoles of wild-type yeast cells
(3, 33, 34). It is interesting that although vps34 mutants
appear to be competent for vacuole assembly, they are
grossly defective in the delivery of several vacuolar hydro-
lases, including CPY, PrA, and PrB (Fig. 3; 36). Several
different models may be proposed to explain this apparent
paradox. Multiple, possibly overlapping, pathways may ex-
ist for the delivery of vacuolar constituents from the Golgi
complex. This appears to be the case for mammalian lyso-
somal proteins, as only a subset of all lysosomal constituents
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utilize the mannose-6-phosphate targeting system (22). A
second possibility is that the VPS34 gene product acts
relatively early in the vacuolar protein sorting process,
perhaps in the packaging of the vacuolar proteins into their
appropriate vesicular carriers. In this event, vesicular traffic
to the vacuole may proceed almost normally except that the
vesicles would lack much of their usual protein content. In
both models, vacuole assembly could proceed in the absence
of VPS34 gene function but vacuolar functions would be
compromised since many vacuolar proteins would now be
mislocalized.
During our analysis of the vacuolar compartment in
Avps34 mutants, we observed that more than 80% of the
newly forming buds lacked a detectable vacuole. In contrast,
a normal vacuolar structure was generally observed in the
mother cell and in the majority of the unbudded cells in the
Avps34 population. Therefore, the inheritance and assembly
of the vacuolar structure in dividing Avps34 cells appear to
be delayed relative to the processes in wild-type yeast cells.
In wild-type cells, a vacuole is detected in the bud when it is
only a fraction of the size of the mother cell (Fig. 8A; 53).
Analyses of vacuole segregation during cell division have
indicated that the daughter bud inherits a substantial portion
of its vacuolar contents from the mother cell vacuole (45, 53,
5, 58; this inheritance pathway is shown as pathway 1 in Fig.
8B). The absence of a vacuole in the newly emerging bud in
Avps34 cells could reflect a defect in vacuolar inheritance.
Similar defects in vacuolar segregation have been observed
in two other yeast mutants, vacl (54) and vps3 (35). Com-
plementation tests have demonstrated that the vps34, vacl,
and vps3 mutations define different yeast genes (21; L.
Weisman and W. Wickner, personal communication). At
least two different models could be proposed to explain this
apparent defect in vacuole segregation in Avps34 cells.
Vacuolar segregation and Golgi-to-vacuole protein transport
may be mechanistically similar, and Vps34p may be required
to execute a common event along both pathways. Alterna-
tively, the severe missorting defects associated with vps34
mutations could result in a decrease in specific vacuolar
activities that are required for vacuolar inheritance. Further
genetic and biochemical studies are required to determine
the precise role of Vps34p in the partitioning of vacuolar
contents between mother and daughter yeast cells.
We believe that the data presented here are most consis-
tent with Vps34p being directly involved in the sorting of
proteins to the yeast vacuolar compartment. In a population
of vps34 cells, the majority of the cells exhibit a normal
vacuole morphology, yet CPY is almost quantitatively mis-
localized to the cell surface. The observation that vps34 cells
are competent for vacuole assembly indicates that at least
some vacuolar constituents are properly delivered to this
organelle. The severe vps34 missorting defects would be
expected to result in a significant decrease in a variety of
normal vacuolar activities. Such a decrease in vacuolar
function may be responsible for the phenotypes associated
with vps34 alleles, including temperature-sensitive growth,
osmosensitivity, and the vacuolar segregation defect. On the
basis of our observations, we propose that Vps34p may be a
component of a relatively large multiprotein structure that
functions to facilitate specific steps of the vacuolar protein
sorting pathway.
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